Schedule 13D ownership disclosure
CYTOMED THERAPEUTICS LIMITED
Security class unavailable · CUSIP: Y1R80M106
Event date: 2023-04-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 28.8600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-23-013202
- Form type
- SC 13D
- Filer
- Choo Chee Kong
- CIK
- CIK 1970632
- Filed
- Apr 21, 2023
- Reporting period
- Apr 14, 2023
- Description
- Schedule 13D beneficial ownership